COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
Abstract
Authors
A.D. Piedade L. Paladini J.S. Alves T.d. Gonçalves F. Griciunas